Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats. - Wikidata - wikimedia - TriplyDB

Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats.

Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats.

http://www.wikidata.org/entity/Q34032089

about

The use of fibroblast growth factor 23 testing in patients with kidney disease.The influence of vitamin D analogs on calcification modulators, N-terminal pro-B-type natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study.Vitamin D deficiency and essential hypertension.The therapeutic role of monocyte chemoattractant protein-1 in a renal tissue engineering strategy for diabetic patients Cardiovascular effects of cholecalciferol treatment in dialysis patients--a randomized controlled trial.Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats.Vitamin D status is not related to development of atrial fibrillation in the community.Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease Vitamin D therapy in chronic kidney disease and end stage renal disease.Extraskeletal actions of vitamin D.The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection.Vitamin D: roles in renal and cardiovascular protection.Impact of activated vitamin D on insulin resistance in nondiabetic chronic kidney disease patients.Molecular mechanism of vitamin D in the cardiovascular system Vitamin D increases plasma renin activity independently of plasma Ca2+ via hypovolemia and β-adrenergic activity.CKD-Mineral Bone Disorder in Stage 4 and 5 CKD: What We Know Today?Vitamin D and the heart.FGF23 modifies the relationship between vitamin D and cardiac remodeling.Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats.Shining D' light on chronic kidney disease: mechanisms that may underpin the cardiovascular benefit of vitamin D.New roles for renin and prorenin in heart failure and cardiorenal crosstalk.Vitamin D receptor activation and cardiovascular disease.What have we learned about chronic kidney disease-mineral bone disorder from the EVOLVE and PRIMO trials?Vitamin D supplements in chronic kidney disease.The protective role of vitamin D on the heart and the kidney.Mineral metabolism and cardiovascular disease in CKD.Severely vitamin D-deficient athletes present smaller hearts than sufficient athletes.1,25-Dihydroxyvitamin D₃ suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activation.Involvement of the Vitamin D Receptor in Energy Metabolism Revealed by Profiling of Lysine Succinylome of White Adipose Tissue.Vitamin D deficiency is associated with increased left ventricular mass and diastolic dysfunction in children with chronic kidney disease.Cardioprotective effect of calcitriol on myocardial injury induced by isoproterenol in rats.Vitamin D protection from rat diabetic nephropathy is partly mediated through Klotho expression and renin-angiotensin inhibition.Oral paricalcitol: expanding therapeutic options for pediatric chronic kidney disease patients.The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease.Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria.The Vitamin D Receptor Activator Maxacalcitol Provides Cardioprotective Effects in Diabetes Mellitus.

P2860

Q33835743-3B3DEA0B-EF67-4A43-9159-C9306A07BBD7 Q34059805-8D410BA8-DB0F-4E10-96D5-EC7B3A82DCEC Q34496209-CF61BC2F-346F-424A-9445-FD8B57989EAA Q34603718-50253BC1-49F1-4CE6-B48F-D1E6E848AE83 Q35128801-4879F48B-FE07-4326-8947-5B064AF8DD02 Q35167070-08A4878D-0A93-41A1-ADF0-98A0B663FE7B Q35207725-42A1D750-770D-4883-BA03-EAB158C4BC15 Q35210184-EA191617-FB61-4872-AA0D-386F48042CB4 Q35758581-9514D2D2-DA7D-4B9F-B231-5BFB7E2F8296 Q36138538-9F653DBD-F044-4A60-9EAE-3656740CF432 Q36613869-8BDC12C7-E7F0-4A9B-BC95-901CD4B50AFC Q36614706-E06617FE-444D-4119-84E0-C5BF38E9BC51 Q36802341-DDFC4E6D-CF72-4A90-A58D-5156CBB6DF6D Q36821166-204C19AC-9170-4ABD-8637-1566DC368A07 Q37234733-BA93EBCF-A63D-41B3-85A9-0FA513C0B9EA Q37279085-EAF81BA3-2A03-4252-8E07-C35E7E70AB77 Q37342339-933430B2-A79B-49AA-8219-587218D9DF4E Q37401743-D27520C6-8FC8-486D-A6EC-3DB206AD0FE7 Q37690771-DF7B3210-9A6E-4C18-8798-AC007A0BD129 Q37842680-3D18E953-69EE-47DA-9A02-20FF74C58010 Q37893014-A1C7057D-8269-4D94-8BAE-2C75AC17AF18 Q38069143-12A25F03-5417-49E1-AD44-F00E6058889C Q38150052-D8390BAB-E47D-4D0A-8A0D-0CE76CA6AAEB Q38554471-F241397D-7591-4190-A3A8-7814EDB8364B Q38991955-1463A19C-0EEA-44D9-BAA4-28C7711AB9B3 Q39072097-312AF174-D30E-4BA2-89DF-5AF4D9D5672A Q39277994-6EE85EB1-3342-4379-ADED-3BC3AF9F90CD Q41872361-BA838A75-5551-454E-874A-C195D454051C Q42621071-AFDA9B68-4208-429F-A367-D9CDCF235EE8 Q45373448-8442CFE0-AD73-4023-9232-221055564AAD Q46138257-59D33CAB-2B1F-4AB8-B558-E4EF3DE34107 Q47225498-B46DFDE2-9453-4F17-8AA1-30BEFDD957D1 Q48047762-8D40C37A-334D-4927-A1A7-78CC695590F7 Q50101289-F1340B10-26FC-4E37-8DAC-7E8727C65E5B Q50433834-57B74E2A-0E3A-4DAD-AAC0-6A5C10C1A196 Q52146506-BAD01B6E-05D9-4C6F-9180-4C82323E2A7F

P2860

Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats.

http://www.wikidata.org/entity/Q34032089

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Therapeutic effects of vitamin ...... ontaneously hypertensive rats.

@ast

Therapeutic effects of vitamin ...... ontaneously hypertensive rats.

@en

Therapeutic effects of vitamin ...... ontaneously hypertensive rats.

@nl

type

label

Therapeutic effects of vitamin ...... ontaneously hypertensive rats.

@ast

Therapeutic effects of vitamin ...... ontaneously hypertensive rats.

@en

Therapeutic effects of vitamin ...... ontaneously hypertensive rats.

@nl

prefLabel

Therapeutic effects of vitamin ...... ontaneously hypertensive rats.

@ast

Therapeutic effects of vitamin ...... ontaneously hypertensive rats.

@en

Therapeutic effects of vitamin ...... ontaneously hypertensive rats.

@nl

P1433

Q34032089-9C20D743-6213-4403-AC1E-CB4A4D5B6EE5

P1476

Q34032089-E5E83686-CF3D-4709-B246-2F7AFC790647

P2093

Q34032089-226E2142-4989-4DA5-BEFB-6C878F628B0B

Q34032089-50E8E644-E1AF-468E-9483-E7A5091E850A

Q34032089-5E39B0CA-C8BE-4611-B2E0-8EEF678784E8

Q34032089-982F10AD-7802-4745-BBC2-BEA245C13D43

Q34032089-BDD32A4F-7A8D-497C-A231-09DFCBA7DEDB

Q34032089-C5AB99F9-1BB4-4267-A55B-CF800EB649A0

Q34032089-C6DDA2BD-7D9B-4F41-89B7-E53AF24DA48B

Q34032089-CBA1E40D-EF15-4836-9A84-6AF89F6E8CFE

Q34032089-DFF8976F-4A3A-4602-875F-4D96C0679676

Q34032089-E99B4ACF-6594-4C67-8AEB-E003106184E7

P2860

Q34032089-08B8322D-4762-4608-858C-698942F00E8B

Q34032089-0A686972-4669-435E-BB8F-7C3347C565F1

Q34032089-0F86F312-0BB5-4C15-B402-8CC97EB5F79C

Q34032089-12A5D4FA-79CA-4DE9-88D8-A1B88CC1BC95

Q34032089-19FF4710-571A-470B-BA41-991A5EE7DD71

Q34032089-23158880-A444-46AC-BB0D-61BA16A8F713

Q34032089-2D266ECE-A64B-4BA5-8F74-58C2BB1E8707

Q34032089-39C6E04C-4E1E-4830-8541-5BC1E30197AC

Q34032089-40E92F48-457C-4349-9061-B35FD7AE6897

Q34032089-42E69A7C-FB40-455F-9989-013572305868

P304

Q34032089-1330507F-D8A6-434E-8752-3137AB727CD0

P31

Q34032089-71BDB114-4F2C-4D92-9393-B61A2E191C31

P356

Q34032089-31B812AC-0E24-4FBC-9BB9-400510DECF62

P407

Q34032089-9E930CE0-D5B8-444A-8A6B-8D436C5EF1D9

P433

Q34032089-F5205290-7BBB-4C03-A296-B79169F6DB92

P478

Q34032089-0554C6EE-791F-4156-8B7E-9497BE4FC314

P577

Q34032089-3B3B7E63-0671-43F6-83AA-950A5450C364

P5875

Q34032089-07696D2C-23F4-4125-B57B-79F59C3423E4

P698

Q34032089-6550828E-6616-4961-B5FF-405A92F641CD

P921

Q34032089-70421535-8531-4C6C-ADA3-65CB42C488A8

P932

Q34032089-7D1B5D4B-3D63-44F0-B864-61B1FD040783

P356

AJPATH.2010.091292

P1433

The American Journal of Pathology

P1476

Therapeutic effects of vitamin ...... ontaneously hypertensive rats.

@en

P2093

Gene H Kim

http://www.w3.org/2001/XMLSchema#string

George Li

http://www.w3.org/2001/XMLSchema#string

Ishir Bhan

http://www.w3.org/2001/XMLSchema#string

Juan Kong

http://www.w3.org/2001/XMLSchema#string

Minjie Wei

http://www.w3.org/2001/XMLSchema#string

Qun Zhao

http://www.w3.org/2001/XMLSchema#string

Ravi Thadhani

http://www.w3.org/2001/XMLSchema#string

Shu Q Liu

http://www.w3.org/2001/XMLSchema#string

Tao Sun

http://www.w3.org/2001/XMLSchema#string

Xinmin Li

http://www.w3.org/2001/XMLSchema#string

P2860

Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin

Genomic sequencing

25-hydroxyvitamin D levels and the risk of mortality in the general population

Structure-based design of aliskiren, a novel orally effective renin inhibitor

Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril

Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response

Control of stress-dependent cardiac growth and gene expression by a microRNA

Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey.

Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter.

Vitamin D deficiency and risk of cardiovascular disease.

P304

622-631

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2010.091292

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

177

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45113886

http://www.w3.org/2001/XMLSchema#string

P698

20616348

http://www.w3.org/2001/XMLSchema#string

P921

P932

2913045

http://www.w3.org/2001/XMLSchema#string